|

Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Pipeline

Phase 2: 1

Top Sponsors

  • Masonic Cancer Center, University of Minnesota1

Indications

  • High Grade Non-Hodgkin's Lymphoma, Adult1
  • Fetal Hemoglobin1
  • Chromosome Abnormality1
  • Monosomy 71
  • CBL Gene Mutation1

Minneapolis, Minnesota1 trial

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

University of Minnesota Masonic Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.